Clinical characteristics and natural history of patients with low-grade reflux esophagitis

被引:64
作者
Manabe, N
Yoshihara, M
Sasaki, A
Tanaka, S
Haruma, K
Chayama, K
机构
[1] Hiroshima Univ, Sch Med, Dept Internal Med 1,Gastrointestinal Unit, Minami Ku, Hiroshima 7348551, Japan
[2] Hiroshima Univ, Sch Med, Dept Endoscopy, Hiroshima 7348551, Japan
[3] Kawasaki Med Sch, Dept Internal Med, Div Gastroenterol 2, Kurashiki, Okayama, Japan
关键词
esophageal motility; Helicobacter pylori; natural history; reflux esophagitis;
D O I
10.1046/j.1440-1746.2002.02783.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aim: Although the incidence of reflux esophagitis (RE) has recently increased in Japan, the majority of these cases are mild (Los Angeles classification grades A and B). In order to consider therapy for these patients, it is important to understand the natural history of mild RE. There is little information concerning the natural course of RE, particularly low-grade disease. The goal of this study is to elucidate the natural course of patients with mild RE and to identify specific prognostic indicators associated with a poor outcome. Methods: One hundred and five patients with mild RE were followed, without medical treatment, by endoscopy in addition to a questionnaire regarding symptomatology, for a mean of 5.5 years (range, 2.0-8.8 years) after initial diagnosis. Factors associated with the development of severe esophagitis were analyzed. Results: Endoscopically, 11 patients (10.5%) progressed to more severe forms of RE (recurrent progressive (RP) group), 60.0% of patients relapsed without disease progression (recurrent non-progression group), and the remaining 29.5% of patients had no further episodes of RE (isolated episode group). Risk factors for progressive disease were increased age, female sex, the presence of symptoms at initial diagnosis by endoscopy, presence of a hiatal hernia, absence of atrophic gastritis, and absence of Helicobacter pylori infection. Despite having all risk factors, there were six patients who did not progress to more severe forms of RE. The primary esophageal peristaltic amplitude in these patients was significantly higher than in the RP group. Conclusions: Among patients with mild RE, only 10.5% progressed to more severe forms of RE. The patients with risk factors are candidates for aggressive therapy in order to prevent the progression of the RE disease process. (C) 2002 Blackwell Publishing Asia Pty Ltd.
引用
收藏
页码:949 / 954
页数:6
相关论文
共 29 条
  • [1] Armstrong D, 2001, AM J GASTROENTEROL, V96, P2849
  • [2] The endoscopic assessment of esophagitis: A progress report on observer agreement
    Armstrong, D
    Bennett, JR
    Blum, AL
    Dent, J
    deDombal, FT
    Galmiche, JP
    Lundell, L
    Margulies, M
    Richter, JE
    Spechler, SJ
    Tytgat, GNJ
    Wallin, L
    [J]. GASTROENTEROLOGY, 1996, 111 (01) : 85 - 92
  • [3] Bardhan KD, 1996, YALE J BIOL MED, V69, P211
  • [4] CONCENTRATION OF REFLUXED ACID AND ESOPHAGEAL MUCOSAL INJURY
    BREMNER, RM
    CROOKES, PF
    DEMEESTER, TR
    PETERS, JH
    STEIN, HJ
    [J]. AMERICAN JOURNAL OF SURGERY, 1992, 164 (05) : 522 - 527
  • [5] SEVERE PEPTIC OESOPHAGITIS
    BRUNNEN, PL
    KARMODY, AM
    NEEDHAM, CD
    [J]. GUT, 1969, 10 (10) : 831 - &
  • [6] OMEPRAZOLE V RANITIDINE FOR PREVENTION OF RELAPSE IN REFLUX ESOPHAGITIS - A CONTROLLED DOUBLE-BLIND TRIAL OF THEIR EFFICACY AND SAFETY
    DENT, J
    YEOMANS, ND
    MACKINNON, M
    REED, W
    NARIELVALA, FM
    HETZEL, DJ
    SOLCIA, E
    SHEARMAN, DJC
    [J]. GUT, 1994, 35 (05) : 590 - 598
  • [7] Quality of life in patients with upper gastrointestinal symptoms: Results from the Domestic/International Gastroenterology Surveillance Study (DIGEST)
    Enck, P
    Dubois, D
    Marquis, P
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1999, 34 : 48 - 54
  • [8] AGE-RELATED AND GENDER-RELATED DIFFERENCES IN 24-HOUR ESOPHAGEAL PH MONITORING OF NORMAL SUBJECTS
    FASS, R
    SAMPLINER, RE
    MACKEL, C
    MCGEE, D
    RAPPAPORT, W
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (10) : 1926 - 1928
  • [9] OMEPRAZOLE AND RANITIDINE IN TREATMENT OF REFLUX ESOPHAGITIS - DOUBLE-BLIND COMPARATIVE TRIAL
    HAVELUND, T
    LAURSEN, LS
    SKOUBOKRISTENSEN, E
    ANDERSEN, BN
    PEDERSEN, SA
    JENSEN, KB
    FENGER, C
    HANBERGSORENSEN, F
    LAURITSEN, K
    [J]. BRITISH MEDICAL JOURNAL, 1988, 296 (6615) : 89 - 92
  • [10] HEALING AND RELAPSE OF SEVERE PEPTIC ESOPHAGITIS AFTER TREATMENT WITH OMEPRAZOLE
    HETZEL, DJ
    DENT, J
    REED, WD
    NARIELVALA, FM
    MACKINNON, M
    MCCARTHY, JH
    MITCHELL, B
    BEVERIDGE, BR
    LAURENCE, BH
    GIBSON, GG
    GRANT, AK
    SHEARMAN, DJC
    WHITEHEAD, R
    BUCKLE, PJ
    [J]. GASTROENTEROLOGY, 1988, 95 (04) : 903 - 912